Boston CEO 2024

Boston CEO, held October 28-29, 2024 at the Mandarin Oriental Hotel, brought together roughly 300 leaders in the life sciences across government, pharma, biotech, academia, and investing communities for two days of interactive dialogue on some of the most important issues facing the industry.

Featured Speakers

Over 140 speakers joined discussion panels, fireside chats, and roundtable discussions to share their insights on a wide range of topics impacting the healthcare environment. Thought leaders and stakeholders hailed from a range of important sectors, including the following featured speakers:

Academia & Research

Alan Garber

President
Harvard University

Susan Hockfield

President Emerita
MIT

Anne Klibanski

CEO
Mass General Brigham

Sally Kornbluth

President
MIT

Bob Weinberg

Founding Member
Whitehead Institute, MIT

Regulatory & Public Policy

Maura Healey

Governor
Commonwealth of Massachusetts

Thomas Lonngren

former Executive Director
EMA

Edward J. Markey

Senator
Commonwealth of Massachusetts

Peter Marks

Director, CBER
FDA

Michelle Wu

Mayor
City of Boston

R&D Leaders

Levi Garraway

CMO
Roche Genentech

Fiona Marshall

President, Biomedical Research
Novartis

Robert Plenge

EVP, Chief Research Officer,
Head of Research
Bristol Myers Squibb

Marcus Schindler

CSO & EVP, Research & Early Development
Novo Nordisk

George Yancopoulos

President & CSO
Regeneron

BioPharma CEOs

Harvey Berger

CEO
Kojin Therapeutics

Rachel Humphrey

CEO
Normunity

Rosana Kapeller

CEO
Rome Therapeutics

Ed Kaye

CEO
Stoke Therapeutics

John Lepore

CEO
ProFound Therapeutics

Caroline Loew

CEO
Mural Oncology

Ted Love

Chair
BIO

Mathai Mammen

CEO
FogPharma

John Maraganore

former CEO
Alnylam

Andrew Obenshain

CEO
bluebird bio

BD & Strategy

Rachid Izzar

EVP, Head, Global Product Strategy & Commercialization
Biogen

Stu Mackey

Global Head, BD
Daiichi Sankyo

Raj Prasad

CFO
CRISPR Therapeutics

Deniz Razon

CBO
Servier Pharmaceuticals

Chris Sheldon

SVP, Global Head, BD
GSK

Investor Perspectives

Jessica Chutter

Managing Director, Chair, Biotechnology Investment Banking
Morgan Stanley

Ansbert Gadicke

Managing Partner
MPM BioImpact

Jørgen Petersen

Senior Partner
Novo Holdings

Claudine Prowse

Venture Partner
JP Morgan Asset Management

Christoph Westphal

General Partner
Longwood Fund

BOSTON CEO 2024 HIGHLIGHTS

Several dynamic networking opportunities interspersed the two day agenda. Meeting participants enjoyed convening with a senior peer group in between dynamic and timely discussion panels and following inspiring key opinion leaders.